Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial

Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T09:51:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:09:29.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed objectives and criteria for a clinical study on BI 695500 versus rituximab in treating follicular lymphoma. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    32%
    Check dated 2025-04-16T14:41:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:47:10.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:34:18.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:22:09.000Z thumbnail image

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.